Article Versions Notes

Ma M, Tian X, Cao W, Wang C, Zhang Y, Yang J, Cheng S, Gu S, Li J, Zhao Y, et al. CRISP3, a Potential Tumor Suppressor, Inhibits the Progression of High-Grade Serous Ovarian Carcinoma by Modulating the PI3K/AKT Pathway. Biomedicines. 2026; 14(2):471. https://doi.org/10.3390/biomedicines14020471

Ma, Mingjun, Xiu Tian, Weiwei Cao, Chao Wang, Yue Zhang, Jiani Yang, Shanshan Cheng, Sijia Gu, Jianxiao Li, Yaqian Zhao, and et al. 2026. "CRISP3, a Potential Tumor Suppressor, Inhibits the Progression of High-Grade Serous Ovarian Carcinoma by Modulating the PI3K/AKT Pathway" Biomedicines 14, no. 2: 471. https://doi.org/10.3390/biomedicines14020471

Ma, M., Tian, X., Cao, W., Wang, C., Zhang, Y., Yang, J., Cheng, S., Gu, S., Li, J., Zhao, Y., Shao, Y., Huang, C., Shi, S., Xue, R., Chu, C., Sheng, J., & Wang, Y. (2026). CRISP3, a Potential Tumor Suppressor, Inhibits the Progression of High-Grade Serous Ovarian Carcinoma by Modulating the PI3K/AKT Pathway. Biomedicines, 14(2), 471. https://doi.org/10.3390/biomedicines14020471